ACTA2 and liver cancer: The expression of inflammation-related marker TNF-α, EMT-related marker ACTA2, and proliferation marker Ki67 was approximately 25-fold, 3-fold, and 2-fold higher in patient-derived liver cancer organoids, respectively, compared to normal liver organoids (Fig. 6B).